drugset / Trial / NCT05180461
Emodepside Phase II Trial for Treatment of Onchocerciasis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The trial evaluates safety, tolerability, pharmacodynamics, pharmacokinetics, dose-response, and efficacy of emodepside tablets, administrated as a range of dose regimens, in adults infected with Onchocerca Volvulus.
Timeline
- Start
- 2021-08-30
- Primary completion
- 2026-09-18
- Completion
- 2026-10-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Emodepside | Small molecule | 15 mg | — |
| Subject | Emodepside | Small molecule | 30 mg | — |
| Comparator | Ivermectin | Small molecule | 150 ug/kg | Oral |